Thursday, June 27
A lot of ink has been spilled on the topic of prescription drug prices and how Congress can address out-of-pocket costs for Americans. Unfortunately, much of the narrative has been shaped by incomplete press reports and over-simplified talking points that wrongly point the finger at pharmacy benefit companies (PBMs).
The core mission of PBMs is to ensure that patients have affordable access to the drugs they need, which means driving down costs for the health care system. Because of the savings that PBMs secure for patients and plan sponsors — including employers, labor unions, and health insurers — drug companies who want to be paid more...
Read More: Medium
Comments